RD3
Protein RD3
Also known as: C1orf36, LCA12, RD3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z3Z2
- Gene
- RD3
- Ensembl
- ENSG00000198570
- Chromosome
- 1
- Canonical length
- 195 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a retinal protein that is associated with promyelocytic leukemia-gene product (PML) bodies in the nucleus. Mutations in this gene cause Leber congenital amaurosis type 12, a disease that results in retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
195 residues, UniProt reviewed canonical sequence.
>Q7Z3Z2|RD3
1 MSLISWLRWN EAPSRLSTRS PAEMVLETLM MELTGQMREA ERQQRERSNA VRKVCTGVDY
61 SWLASTPRST YDLSPIERLQ LEDVCVKIHP SYCGPAILRF RQLLAEQEPE VQEVSQLFRS
121 VLQEVLERMK QEEEAHKLTR QWSLRPRGSL ATFKTRARIS PFASDIRTIS EDVERDTPPP
181 LRSWSMPEFR APKADLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 44 nTPM
Expression across tissuesHPA
Tissue
- retina: 44 nTPM
- choroid plexus: 1.6 nTPM
- adrenal gland: 0.6 nTPM
- epididymis: 0.6 nTPM
- pituitary gland: 0.4 nTPM
- endometrium: 0.3 nTPM
Single-cell type
- cone photoreceptor cells: 265 nCPM
- retinal bipolar cells: 185 nCPM
- rod photoreceptor cells: 176 nCPM
- mast cells: 53 nCPM
- thyrotrophs: 13 nCPM
- adrenal medulla cells: 11 nCPM
Immune cell
- eosinophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 3.1 nTPM
- hypothalamus: 2.9 nTPM
- cerebellum: 2.8 nTPM
- basal ganglia: 1.8 nTPM
- hippocampal formation: 1.8 nTPM
- amygdala: 1.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RD3.
Disease | AllUniProt
Conditions RD3 is implicated in, by any mechanism.
- Leber congenital amaurosis 12 (LCA12) MIM:610612
Disease | GeneticClinVar
14 pathogenic / likely-pathogenic of 252 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Leber congenital amaurosis 12
- Retinal dystrophy
- Leber congenital amaurosis
- Abnormality of the eye
- RD3-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.73
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.61
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- protein transport
- retina development in camera-type eye
- visual perception
- negative regulation of guanylate cyclase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RD3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RD3 as an antibody target. Whether an autoantibody or antibody against RD3 could matter depends on whether native RD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RD3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...